Trial ID 19109 | Maryland Oncology Hematology Trial ID 19109 – Maryland Oncology Hematology

Trial ID 19109

Trial Information - Phase I

A PHASE I DOSE ESCALATION AND EXPANDED COHORT STUDY OF PF-06821497 IN THE TREATMENT OF ADULT PATIENTS WITH RELAPSED/REFRACTORY SMALL CELL LUNG CANCER (SCLC), CASTRATION RESISTANT PROSTATE CANCER (CRPC) AND FOLLICULAR LYMPHOMA (FL)

Disease Specifics: Follicular Lymphoma

Protocol ID: C2321001

Sponsor: Pfizer

Status: OPEN TO ENROLLMENT

Contact us regarding Clinical Trials at MOHRSCH@usoncology.com
or call us at 877-664-7724

Disease Types

Lymphoma

Status

OPEN TO ENROLLMENT

Sponsor

Pfizer

Quality Care Close to Home


View our locations on map!

Sign Up Today For Our E-Newsletter

  • This field is for validation purposes and should be left unchanged.
United in Healing with The US Oncology Network - Maryland Oncology Hematology